< Back to Newsletter Archive

03.14.2013

BIO INTERNATIONAL CONVENTION

Forbes 30 Under 30 Rising Stars to be Featured at the 2013 BIO International Convention

For the second year in a row, Forbes magazine published its list of the most awe-inspiring rising stars in science and healthcare, all under the age of 30. BIO President and CEO Jim Greenwood will join a select group of these rising stars for a Keynote Luncheon at the 2013 BIO International Convention...

Share:

HEALTH & TECHNOLOGY

Psoriasis Patients Flock to Social Media

About eight in 10 psoriasis patients who use health care social networks say they do so primarily to learn how others manage their disease, and get practical tips and advice they couldn't find elsewhere...

Share:

EMERGING COMPANIES

Nominations Open for the Buzz of BIO

Are you part of an innovative biotech company that is R&D-intensive and is developing strategic partnerships within the industry? Nominate your company to be the Buzz of BIO! Only 40 nominations will be accepted in total...

Share:

AGRICULTURE

Debunking Ag Biotech's Top 5 Myths

In a detailed article chock full of scientific cites, science writer Ronald Bailey debunks agricultural biotechnology myths...

Share:

INDUSTRY ANALYSIS

BIO-Europe Spring Opening Remarks

BIO's own David Thomas, Director of Industry Research, delivered opening remarks at the BIO-Europe Spring conference in Barcelona yesterday...

Share:

BIO INTERNATIONAL CONVENTION

Convention Veterans Putting the "Super" in Super Sessions

two of our Super Session participants will once again join us to host a dynamic group of C-level industry thought leaders, sharing their perspectives on the current economic environment and major trends that will impact the future of the global industry...

Share:

AGRICULTURE

Face of a Giant Agribusiness

The HuffPost blog promises "fresh takes," but this outlet is often critical of mainstream agriculture and large-scale food production — ironically, the very essence of how we feed 7 billion people in this world...

Share:

HEALTH

The Michael J. Fox Foundation Launches New Funding Opportunities

The Michael J. Fox Foundation (MJFF) is committed to sharing the risk of drug development with researchers from academia and industry alike in order to keep promising research moving forward...

Share:

ORPHAN DISEASE

A Bright Future for Orphan Disease Indications

In celebration of National Rare Disease Day BIO’s Industry Analysis team took a look at recently-approved drugs in the BioMedTracker database with an orphan indication designation...

Share:

RARE DISEASE

Navigating the Rare Disease World

The international orphan drug marketplace is expected to grow some 30 percent by 2014, fueled by the entrance of big pharmaceutical companies and U.S. legislation favoring development and coverage...

Share:

GMOS

BIO Statement on Whole Foods Announcement to Label all GMOs Products in their Stores by 2018

Whole Foods announced that it will require the makers of food products sold in its stores to state on the label if a product contains an ingredient produced through agricultural biotechnology...

Share:

World Congress on Industrial Biotechnology

BIO’s 10th Annual World Congress to Feature Presentations on Latest in Advanced Biofuels, Renewable Chemicals and Commercialization

Global biofuel and renewable chemical company executives and managers developing strategies to further commercialization will speak in breakout sessions at BIO’s World Congress on Industrial Biotechnology this June...

Share:

BIODEFENSE

BIO Praises the U.S. House of Representatives for Passing the Pandemic and All-Hazards Preparedness Reauthorization Act

On March 4, 2013, the U.S. House of Representatives passed PAHPRA by a vote of 370-28...

Share:

press release

2013 BIO International Convention Super Sessions to Highlight State of the Industry, Global Innovation and the Affordable Care Act

The 2013 BIO International Convention will feature six diverse Super Sessions highlighting pressing industry topics...

Share:

Conferences & Events

04.22.13

2013 BIO International Convention

Join us in Chicago for the 2013 BIO International Convention. 16,500 people. 65 countries. 4,000 companies. 25,000 partnering meetings. BIO delivers the business opportunities to you. Today is your last chance to save up to $600 on registration...

Register

03.25.13

BIO IPCC Conference

Over the past nine years, BIO's semiannual IP Counsels Committee Conference has become a popular and growing event among our members' IP and legal professionals...

Register

04.19.13

BIO Executive Training Programs

The Business Development Basics and Advanced Business Development courses support the activity that takes place at our partnering, investor and venture capital conferences...

Register

06.16.13

World Congress on Industrial Biotechnology

The BIO World Congress on Industrial Biotechnology is the world's largest industrial biotechnology event for business leaders, investors, and policy makers in biofuels, biobased products, and renewable chemicals...

Register

10.08.13

BIO Investor Forum

The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies...

Save the Date

November 2013

BIO Convention in China

The BIO Convention in China brings together executives from biotechnology, pharmaceutical companies and investment firms from North America, Europe and Asia to meet and explore business opportunities with China's emerging biotech sector...

SAVE THE DATE

12.08.13

Pacific Rim Summit on Industrial Biotechnology & Bioenergy

The Pacific Rim Summit on Industrial Biotechnology and Bioenergy is the original conference dedicated solely to the growth of the industrial biotechnology and bioenergy sectors in North America and the Asia-Pacific region...

SAVE THE DATE

FEATURED VIDEO

ON FACEBOOK.COM/IAMBIOTECH

CEO OF THE FUTURE — What skills will define biopharma's new leaders? http://ow.ly/inJko

6 LIKES | JOIN

ON Twitter.COM/IAMBIOTECH

Top 10-biotechnology developments ow.ly/ibeVY

19 Retweets | JOIN

ON Linkedin.COM

GMO Labeling May Violate the First Amendment

43 Comments | JOIN

Polls & Quizzes

Which year saw the greatest number of approvals of therapies for orphan indications since 2000?

© 2012 Biotechnology Industry Organization. All rights reserved
About BIO | Privacy Policy | Terms of Use | Subscribe | Unsubscribe | Feedback | Advertising